ஸ்டீவன் பைண்டர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஸ்டீவன் பைண்டர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஸ்டீவன் பைண்டர் Today - Breaking & Trending Today

MannKind Corporation (MNKD) Q1 2021 Earnings Call Transcript


Operator
Good afternoon, and welcome to MannKind Corporation first-quarter 2021 earnings call. As a reminder this call is being recorded on May 12th, 2021, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until May 26, 2021. This call will contain forward-looking statements. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from these stated expectations.
For further information on the company s risk factors please see their 10-Q report filed with the Securities and Exchange Commission this morning, the earnings release and the slides prepared for this presentation. Joining us today from Mannkind are Chief Executive Officer Michael Castagna, and Chief Financial Officer Steven Binder. I would now like to turn the conference over to Mr. Castagna. ....

United States , Oren Livnat , Steven Binder , Michael Castagna , Stephen Lichtman , Robert Hazlett , Steve Binder , Thomas Smith , Connor Daly , Exchange Commission , Mannkind Corporation , Stephen Lichtman Oppenheimer Co , Receptor Life Sciences , Oren Livnat Hc Wainwright Co , Amann Group , Chief Executive Officer Michael Castagna , Chief Financial Officer Steven , United Therapeutics , Receptor Life , Levin Type , ஒன்றுபட்டது மாநிலங்களில் , ஒரேன் லிவ்னாட் , ஸ்டீவன் பைண்டர் , மைக்கேல் காஸ்டஞ , ராபர்ட் ஹேஸ்லெட் , ஸ்டீவ் பைண்டர் ,

MannKind Reduces Debt by Nearly $50 Million | San Fernando Valley Business Journal


 
MannKind Corp. has reduced its debt by $49.5 million through a paid note to the Mann Group and an amended agreement with MidCap Financial Trust, the Westlake Village company said on Monday.
The company broke down the debt reduction as follows: $10 million paid to MidCap, $35.1 million paid to the principal balance of its Mann Group non-convertible note, and $4.4 million paid in accrued interest for the same note.
Through its amended agreement with MidCap, the biotech company’s available borrowings will increase from $25 million to $60 million through June 30 of next year, the company said in a statement. 
Annual interest expense on its remaining debt to MidCap was reduced by $5 million because of a lowered interest rate from 7 to 2.5 percent and an extended maturity date. MannKind’s principal balance with MidCap is currently $40 million. ....

United States , Steven Binder , Midcap Financial , Amann Group , Mannkind Corp , Midcap Financial Trust , Westlake Village , United Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , ஸ்டீவன் பைண்டர் , மான் குழு , வெஸ்ட்லேக் கிராமம் , ஒன்றுபட்டது சிகிச்சை ,